Tus kws kho mob
P12-17 A New Drug, Pharmaceutical Grade L-Glutamine Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2861 - 2870 ntawm 4179
Tus kws kho mob
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P3-17 Added Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2017
Tus kws kho mob
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017
Tus kws kho mob
P52R1-18 Revised: 2019 Minnesota Medicare Network Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
P43R1-18 Revised: Provider Price Disclosure Requirement
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018